• No results found

18 results with keyword: 'systemic lupus erythematosus pathophysiology'

Systemic Lupus Erythematosus Pathophysiology

Induced Glomerular Injury Management and treatment: -Immunosuppressant agents -Mycophenolate Mofetil and intravenous Cyclophosphamide If not treated: -Lupus Nephritis -Acute

Protected

N/A

8
0
0
2021
SAN JOSE STATE UNIVERSITY ONE WASHINGTON SQUARE SAN JOSE, CA 95192

As departments and faculty control and determine the appropriate pedagogies for their courses, the university will not agree in a contract with any private or public entity to deliver

Protected

N/A

6
0
0
2021
DRUGS FOR TREATING SYSTEMIC LUPUS ERYTHEMATOSUS: GLOBAL MARKETS

TREAT SYSTEMIC LUPUS ERYTHEMATOSUS, 2012-2018 (%) 8 FIGURE 1 DIAGNOSIS OF SYSTEMIC LUPUS ERYTHEMATOSUS 32 FIGURE 2 PATIENT CARE PATH IN SYSTEMIC LUPUS ERYTHEMATOSUS 35 FIGURE

Protected

N/A

10
0
0
2021
Elisa Wershba, MD, MPH Pediatric Rheumatologist Phoenix Children s Hospital Clinical Assistant Professor University of Arizona COM- Phoenix

-Lehmann P, Homey B. Clinic and pathophysiology of photosensitivity in lupus erythematosus. Ultraviolet B exposure of peripheral blood mononuclear cells of patients with systemic

Protected

N/A

38
0
0
2021
diagnostics Article Taichung 402, Taiwan 7 Ph.D. Program in Translational Medicine, National Chung Hsing University, Taichung 402, Taiwan

SLE: systemic lupus erythematosus; SLEDAI: Systemic Lupus Erythematosus Disease Activity Index; LN: lupus nephritis; ELISA: enzyme-linked immunosorbent assay; CIA:

Protected

N/A

10
0
0
2021
Health Policy Advisory Committee on Technology New and Emerging Health Technology Report

Abbreviations: RCT: randomised controlled trial; SLE: systemic lupus erythematosus; SLEDAI: systemic lupus erythematosus disease activity index; SSc: systemic sclerosis; *

Protected

N/A

123
0
0
2021
SPECIAL ARTICLE INTRODUCTION

* SLE ⫽ systemic lupus erythematosus; VAS ⫽ visual analog scale; ECLAM ⫽ European Consensus Lupus Activity measurement; SLEDAI ⫽ Systemic Lupus Erythematosus Disease Activity

Protected

N/A

9
0
0
2021
Systemic lupus erythematosus associated with type 4 renal tubular acidosis: a case report and review of the literature

RTA: renal tubular acidosis; SLE: systemic lupus erythematosus; SLEDAI: systemic lupus erythematosus disease activity index; TTKG: transtubular potassium

Protected

N/A

5
0
0
2020
A Study on Pulmonary Manifestations in Systemic Lupus Erythematous

lung disease in systemic lupus erythematosus. Semin Arthritis Rheum. Pulmonary manifestations of. systemic lupus erythematosus. Clin Chest Med. Pulmonary involvement in systemic

Protected

N/A

100
0
0
2019
Successful use of Ustekinumab in a Patient with Psoriasis,
Psoriatic Arthritis and Systemic Lupus Erythematosus: A Case
report and Review of literature

Abbreviations: SLE: Systemic Lupus Erythematosus; CCLE: Chronic Cutaneous Lupus Erythematosus; DLE: Discoid Lupus Erythematosus; PsA: Psoriatic Arthritis; Ps: Psoriasis; TNF:

Protected

N/A

5
0
0
2020
Secondary angle closure glaucoma by lupus choroidopathy as an initial presentation of systemic lupus erythematosus: a case report

Background: We present a rare case of secondary angle closure glaucoma due to systemic lupus erythematosus choroidopathy as initial presentation of systemic lupus

Protected

N/A

7
0
0
2020
Study of Thyroid Dysfunction in Systemic Lupus Erythematosus

Systemic Lupus Erythematosus Having Thyroid

Protected

N/A

102
0
0
2019
Hemoglobinopathy and Systemic Lupus: A Rare Association

(2013) Successful Hematopoietic Cell Transplanta- tion in a Child with Sickle Cell Disease and Systemic Lupus Erythematosus. (2010) The Overlap of Systemic Lupus Erythematosus

Protected

N/A

6
0
0
2020
Systemic Lupus Erythematosus Treatment Market Synopsis

Figure 8 Americas: Systemic Lupus Erythematosus Treatment Market Share, by Region, 2020 Figure 9 North America: Systemic Lupus Erythematosus Treatment Market Share, by Country,

Protected

N/A

10
0
0
2022
SYSTEMIC LUPUS ERYTHEMATOSUS AND SYNDROMES POSSIBLY RELATED

SYSTEMIC LUPUS ERYTHEMATOSUS AND SYNDROMES..

Protected

N/A

17
0
0
2020
Guideline on clinical investigation of medicinal products for the treatment of systemic lupus erythematosus, cutaneous lupus and lupus nephritis

Keywords Lupus, cutaneous (CLE) and systemic lupus erythematosus (SLE), ‘discoid’ lupus erythematosus (DLE), efficacy endpoints, disease activity indices, claims 12... Guideline

Protected

N/A

19
0
0
2021
Systemic lupus erythematosus and thrombosis

SLE: Systemic Lupus Erythematosus; OR: Odds Ratio; aPL: Antiphospholipid antibodies; APS: Antiphospholipid syndrome; SLICC: Systemic Lupus International Collaborating Clinics; LA:

Protected

N/A

10
0
0
2020
Systemic Lupus Erythematosus

It is also critical that rheumatologists and other specialists do not neglect ocular manifestations, thus providing an earlier diagnosis in some patients and better monitoring

Protected

N/A

5
0
0
2021

Upload more documents and download any material studies right away!